Brenda Libby Coleman

Array ( [id] => 11408910 [patent_doc_number] => 09556201 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-31 [patent_title] => 'Bicyclic pyridines and analogs as sirtuin modulators' [patent_app_type] => utility [patent_app_number] => 13/504134 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56255 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5929874 [patent_doc_number] => 20110039833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => '1-BENZOYL SUBSTITUTED DIAZEPINE DERIVATIVES AS SELECTIVE HISTAMINE H3 RECEPTOR AGONISTS' [patent_app_type] => utility [patent_app_number] => 12/912026 [patent_app_country] => US [patent_app_date] => 2010-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12440 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20110039833.pdf [firstpage_image] =>[orig_patent_app_number] => 12912026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10594422 [patent_doc_number] => 09315497 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-19 [patent_title] => 'Tricyclic and tetracyclic systems with activity on the central nervous and vascular systems' [patent_app_type] => utility [patent_app_number] => 13/500983 [patent_app_country] => US [patent_app_date] => 2010-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3607 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5993532 [patent_doc_number] => 20110015185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'Benzofuran Compounds' [patent_app_type] => utility [patent_app_number] => 12/892765 [patent_app_country] => US [patent_app_date] => 2010-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62217 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015185.pdf [firstpage_image] =>[orig_patent_app_number] => 12892765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11784961 [patent_doc_number] => 09394306 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-19 [patent_title] => 'Pyrazoline dione derivatives as NADPH oxidase inhibitors' [patent_app_type] => utility [patent_app_number] => 13/394904 [patent_app_country] => US [patent_app_date] => 2010-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21169 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13394904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8301977 [patent_doc_number] => 20120184537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => '[1,4]-BENZODIAZEPINES AS VASOPRESSIN V2 RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/497231 [patent_app_country] => US [patent_app_date] => 2010-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10917 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8483813 [patent_doc_number] => 20120283220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'ANTOFINE AND CRYPTOPLEURINE DERIVATIVES AS ANTICANCER AGENTS' [patent_app_type] => utility [patent_app_number] => 13/503113 [patent_app_country] => US [patent_app_date] => 2010-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28935 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6137576 [patent_doc_number] => 20110009625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'NOVEL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/883718 [patent_app_country] => US [patent_app_date] => 2010-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 49497 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009625.pdf [firstpage_image] =>[orig_patent_app_number] => 12883718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10122490 [patent_doc_number] => 09156842 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-13 [patent_title] => 'Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-A][1,4]benzodiazepine-4-YL]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process' [patent_app_type] => utility [patent_app_number] => 13/496742 [patent_app_country] => US [patent_app_date] => 2010-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6834 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13496742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6388340 [patent_doc_number] => 20100317654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => '1,4-DIAZA-BICYCLO[3.2.2]NONYL OXADIAZOLYL DERIVATIVES AND THEIR MEDICAL USE' [patent_app_type] => utility [patent_app_number] => 12/861420 [patent_app_country] => US [patent_app_date] => 2010-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6303 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317654.pdf [firstpage_image] =>[orig_patent_app_number] => 12861420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6071258 [patent_doc_number] => 20110046109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => '2,4,8-TRISUBSTITUTED-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE COMPOUNDS AND COMPOSITIONS FOR USE IN THERAPY' [patent_app_type] => utility [patent_app_number] => 12/859645 [patent_app_country] => US [patent_app_date] => 2010-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 49459 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046109.pdf [firstpage_image] =>[orig_patent_app_number] => 12859645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10149020 [patent_doc_number] => 09181295 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-10 [patent_title] => 'Cationic lipids with various head groups for oligonucleotide delivery' [patent_app_type] => utility [patent_app_number] => 13/390702 [patent_app_country] => US [patent_app_date] => 2010-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 10458 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6002995 [patent_doc_number] => 20110118235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'SUBSTITUTED BENZOAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/859182 [patent_app_country] => US [patent_app_date] => 2010-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35191 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118235.pdf [firstpage_image] =>[orig_patent_app_number] => 12859182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8371183 [patent_doc_number] => 20120220571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'HIV INTEGRASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/392169 [patent_app_country] => US [patent_app_date] => 2010-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15520 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9977530 [patent_doc_number] => 09023842 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-05 [patent_title] => 'Benzodiazepine bromodomain inhibitor' [patent_app_type] => utility [patent_app_number] => 13/505039 [patent_app_country] => US [patent_app_date] => 2010-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12861 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10892936 [patent_doc_number] => 08916549 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-23 [patent_title] => 'Thienooxazepine derivative' [patent_app_type] => utility [patent_app_number] => 13/388362 [patent_app_country] => US [patent_app_date] => 2010-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35376 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8982122 [patent_doc_number] => 08513236 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Pterostilbene cocrystals' [patent_app_type] => utility [patent_app_number] => 12/847516 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 24 [patent_no_of_words] => 13693 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12847516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8955955 [patent_doc_number] => 08501728 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-06 [patent_title] => 'Substituted heteroarylamide oxazepinopyrimidone derivatives' [patent_app_type] => utility [patent_app_number] => 12/844270 [patent_app_country] => US [patent_app_date] => 2010-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8824 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12844270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8968659 [patent_doc_number] => 08507470 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-13 [patent_title] => 'Substituted arylamide oxazepinopyrimidone derivatives' [patent_app_type] => utility [patent_app_number] => 12/844275 [patent_app_country] => US [patent_app_date] => 2010-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8843 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12844275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8968664 [patent_doc_number] => 08507475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-13 [patent_title] => 'Substituted heteroarylamide diazepinopyrimidone derivatives' [patent_app_type] => utility [patent_app_number] => 12/844273 [patent_app_country] => US [patent_app_date] => 2010-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10826 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12844273 [rel_patent_id] =>[rel_patent_doc_number] =>)